Fibronostics will be presenting 2 of our clinical studies at the International Liver Congress™ 2022 of the European Association for the Study of the Liver (EASL).
Fibronostics is a healthcare technology company focused on transforming non-invasive solutions for early disease intervention.
© 2022, Fibronostics, All Rights Reserved.
© Copyright Fibronostics. All Rights Reserved